Companies House true 2021-01-01 2021-12-31 false 04566792 uk-bus:Director1 2021-01-01 2021-12-31 04566792 uk-bus:Director2 2021-01-01 2021-12-31 04566792 2021-01-01 2021-12-31 04566792 2021-12-31 04566792 uk-bus:EntityHasNeverTraded 2021-01-01 2021-12-31 04566792 uk-bus:FRS102 2021-01-01 2021-12-31 04566792 uk-bus:FullAccounts 2021-01-01 2021-12-31 04566792 uk-bus:AuditExempt-NoAccountantsReport 2021-01-01 2021-12-31 04566792 2020-12-31 04566792 uk-bus:OrdinaryShareClass1 2021-01-01 2021-12-31 04566792 uk-bus:OrdinaryShareClass2 2021-01-01 2021-12-31 04566792 uk-bus:OrdinaryShareClass3 2021-01-01 2021-12-31 04566792 uk-bus:PreferenceShareClass1 2021-01-01 2021-12-31 04566792 uk-bus:PreferenceShareClass2 2021-01-01 2021-12-31 04566792 uk-bus:PreferenceShareClass3 2021-01-01 2021-12-31 04566792 uk-core:ShareCapitalPreferenceShares 2021-12-31 04566792 uk-core:ShareCapitalPreferenceShares 2020-12-31 iso4217:GBP xbrli:shares

Registered Number 04566792

DISPERSE PHARMA LIMITED

Dormant Accounts

31 December 2021

DISPERSE PHARMA LIMITED Registered Number 04566792

Balance Sheet as at 31 December 2021

2021 2020
£ £
Current assets
Cash at bank and in hand
99
99
Net assets
99
99
Issued share capital
9900 ordinary Shares of £ 0.01 each 99 99
Total Shareholder funds
99
99

STATEMENTS

  1. For the year ending 31 December 2021 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 14 September 2022

And signed on their behalf by:
Richard Twydell, Director
Derek Wheeler, Director